| Publication |
Publisher |
Date |
| Asessing the cytotoxic effects of anti-HIV drug, Garani MWI. |
SMU Medical J 2016: 3(1) |
2016 |
| polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations. |
J. Antimicrob. Chemother. (2014) 69 (12): 3329-3334 |
2014 |
| Peripheral blood mitochondrial DNA/Nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-Infected Malawian patients. |
OMICS J Integrative Biol 2014; 18(7) |
2014 |
| BST-2 proximal promoter polymorphisms in sub-Saharan African populations: implications for HIV-1 prevalence. |
OMICS J Integrative Biol 2014; 18 |
2014 |
| Mitochondrial DNA subhaplogroups L0a2 and L2a modify susceptibility to peripheral neuropathy in Malawian adults on stavudine containing highly active antiretroviral therapy. |
J Acquir Immune Def Syndr 2013; 63(5) 647-652 |
2013 |
| Mitochondria subhaplogroups and differential risk of stavudine-induced lipodystrophyin Malawians HIV/AIDS patients. |
Pharmacogenetics Pharmacogenomics 2013 14:16, 1999-2004 |
2013 |
| Severe toxicity and polymerase- ? gene abnormalities in Malawian adults on stavudine-based antiretroviral therapy. |
Pharmacogenet Genomics 2013; 23: 624-6 |
2013 |
| Longitudinal lactate levels from routine point-of-care monitoring in adult Malawian antiretroviral therapy patients: associations with stavudine toxicities. |
Trans R Soc Trop Med Hyg 2013; 107: 615-9 |
2013 |
| Pharmacogenetics Research Developments in Africa: A Focus on Malawi. |
Curr Pharmacogenomics Person Med 2012; 10: 87-97 |
2012 |
| Stavudine toxicity in adult longer-term ART patients in Blantyre, Malawi. |
PLos One 2012; 16: 2105-17 |
2012 |
| Difference in genetic variants in Lopinavir disposition among HIV Bantu Africans. |
Pharmacogenetics. 2016 |
2016 |
